Super Scan Leading to Definitive Diagnosis in a Patient with Recurrent Syncope

Clinical Nuclear Medicine

Volumn 28, Issue 11, 2003, Pages 886-889

  Khoury, Jabour ^a   Jerushalmi, Jacqueline ^a   Cohen, Hector Isaac ^a   Loberant, Norman ^a   Zaina, Adnan ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

Bone scintigraphy; Mastocytosis; Super scan; Tc 99m MDP

Indexed keywords

ADULT; ARTICLE; BONE DISEASE; BONE MARROW BIOPSY; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; DISEASE ASSOCIATION; HUMAN; MALE; MASTOCYTOSIS; METABOLIC BONE DISEASE; RECURRENT DISEASE; SYNCOPE; SYSTEMIC DISEASE; BONE; MIDDLE AGED; SCINTISCANNING; SYSTEMIC MASTOCYTOSIS;

DIAGNOSTIC AGENT; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

BONE AND BONES; HUMANS; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; RADIOPHARMACEUTICALS; RECURRENCE; SYNCOPE; TECHNETIUM TC 99M MEDRONATE;

EID: 1442286004     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000093084.55297.f5     Document Type: Article

References (33)

1. Caluser CI, Macapinlac HA, Abdel-Dayem HM, et al. Role of Tc-99m MDP planar versus CT in evaluation of the spine in patients with malignant disease. Radiology. 1991;181:221.
2. Even-Sapir E, Martin RH, Barnes DC, et al. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology. 1993;187:193.
3. Nagele-Wohrle B, Nickel O, Hahn K. SPECT bone scintigraphy of benign and malignant lesions of the spine. Neurosurg Rev. 1989;12:281.
4. Karnam U, Rogers A. Systemic mastocytosis. Dig Dis Sci. 1999;17: 299-307.
5. Pauls JD, Brems J, Pockros PJ, et al. Mastocytosis: diverse presentations and outcomes. Arch Intern Med. 1999;159:401-405.
6. Travis WD, Li CY, Bergstralh EJ, et al. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine. 1988;67:345-368.
7. Austen KF. Systemic mastocytosis. N Engl J Med. 1992;326:639-640.
8. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-625.
9. Grieser T, Minne HW. Systemic mastocytosis and skeletal lesions. Lancet. 1997;350:1103-1104.
10. Sostre S, Handler HL. Bony lesions in systemic mastocytosis: scintigraphic evaluation. Arch Dermatol. 1977;113:1245-1247.
11. Lidor C, Frisch B, Gazit D, et al. Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Miner Res. 1990;5:871-876.
12. Rafii M, Firooznia H, Golimbu C, et al. Pathological fracture in systemic mastocytosis. Radiographic spectrum and review of the literature. Clin Orthop. 1983;180:260-267.
13. Azana JM, Torrelo A, Mediero IG, et al. Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol. 1994;11:102-106.
14. Cook JV, Chandy J. Systemic mastocytosis affecting the skeletal system. J Bone Joint Surg [Br]. 1989;71:536.
15. Andrew SM, Freemont AJ. Skeletal Mastocytosis. J Clin Pathol. 1993; Nov;46(11):1033-5.
16. Gagnon JH, Kalz F, Kadri AM, et al. Mastocytosis: unusual manifestation; clinical and radiological changes. Can Med Assoc J. 1975;112: 1329-1323.
17. Delsignore JL, Dvoretsky PM, Hicks DG, et al. Mastocytosis presenting as a skeletal disorder. Iowa Orthop J. 1996;16:126-134.
18. Bateman HE, Shroff V, Centeno LV, et al. Systemic mastocytosis: a diagnostic challenge. Ann Allergy Asthma Immunol. 1995;74:379-386.
19. Casadei R, De Cristofaro R, Ferruzzi A. Systemic mastocytosis with skeletal involvement. Chir Organi Mov. 1991;76:277-295.
20. Lidor C, Hallel T, Oren V. Migratory multiple bone involvement in a patient with systemic mastocytosis. Clin Nucl Med. 1990;15:640-643.
21. Malley MJ, Holmes RA. Mastocytosis: scintigraphic findings with bony involvement. Clin Nucl Med. 1988;13:673-674.
22. Gupta SM, Gupta A, Spencer RP, et al. Bone and spleen lesions in systemic mastocytosis. Clin Nucl Med. 1983;34:8.
23. Rosenbaum RC, Frieri M, Metcalfa DD. Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis. J Nucl Med. 1984;25:859-864.
24. Arrington ER, Eisenberg B, Hartshorne MF, et al. Nuclear medicine imaging of systemic mastocytosis. J Nucl Med. 1976;17:699-701.
25. Granerus G, Roupe G. Increased urinary methylimidazoleacetic acid (MelmAA) as an indicator of systemic mastocytosis. Agents Actions. 1982;12:29-31.
26. Frieri M, Levine MA, Meggs W, et al. Correlates of bone pain in systemic mastocytosis. Clin Res. 1983;31:386A.
27. Valent P, Akin C, Sperr WR, et al. Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression. Int Arch Allergy Immunol. 2002;127:137-139.
28. Hauswirth AW, Sperr WR, Ghannadan M, et al. A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy. Leuk Res. 2002;26:601-606.
29. Biarese V, Raviolo P, Cessarani F, et al. Systemic mastocytosis: a case with diffuse bone involvement. Minerva Med. 1996;87:33-39.
30. Sy WM, Bonventre MV, Camera A. Bone scan in mastocytosis: case report. J Nucl Med. 1976;17:699-701.
31. Chen CC, Andrish MP, Mican JM, et al. A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis. J Nucl Med. 1994;35:1471-1475.
32. Bieler EU, Wohlenberg H, Utech C. Skeletal manifestation of generalized mastocytosis in the skeletal scintigram compared with roentgen finding. Rofo Fortschr Geb Rontgenstr Nuklearmed. 1985;142:552-558.
33. Johansson C, Roupe G, Lindstedt G, et al. Bone density, bone markers and bone radiological features in mastocytosis. Age Aging. 1996;25:1-7.